TY - JOUR
T1 - Detection of human papillomavirus genome and analysis of expression of c-myc and Ha-ras oncogenes in invasive cervical carcinomas
AU - Iwasaka, Tsuyoshi
AU - Yokoyama, Masatoshi
AU - Oh-uchida, Mamoru
AU - Matsuo, Norito
AU - Hara, Kouichi
AU - Fukuyama, Kouzou
AU - Hachisuga, Toru
AU - Fukuda, Kouichi
AU - Sugimori, Hajime
PY - 1992/9
Y1 - 1992/9
N2 - Invasive carcinomas of the uterine cervix of 38 patients were examined for the presence of human papillomavirus (HPV) genomes and for the state of the c-myc and Ha-ras oncogenes. A combination of Southern blot hybridization and polymerase chain reaction revealed the presence of the genome of HPV type 16 in 17 tumors (45%), that of HPV type 18 in 3 tumors (8%), and that of unknown types in 16 others (42%), while no viral DNA sequences were detected in 2 tumors. Of the 38 tumors, c-myc amplification was found in only 1 tumor, while there was no Ha-ras amplification. Overexpression of the c-myc gene was observed in 15 (44%) of the 34 tumors analyzed, while there was no overexpression of Ha-ras. Of the 23 squamous cell carcinomas analyzed, relapse-free rates at 24 months were 55% in tumors with c-myc overexpression and 100% in case of tumors with no c-myc overexpression, respectively. The results suggest the possibility that activation of the c-myc oncogene is involved in tumor progression.
AB - Invasive carcinomas of the uterine cervix of 38 patients were examined for the presence of human papillomavirus (HPV) genomes and for the state of the c-myc and Ha-ras oncogenes. A combination of Southern blot hybridization and polymerase chain reaction revealed the presence of the genome of HPV type 16 in 17 tumors (45%), that of HPV type 18 in 3 tumors (8%), and that of unknown types in 16 others (42%), while no viral DNA sequences were detected in 2 tumors. Of the 38 tumors, c-myc amplification was found in only 1 tumor, while there was no Ha-ras amplification. Overexpression of the c-myc gene was observed in 15 (44%) of the 34 tumors analyzed, while there was no overexpression of Ha-ras. Of the 23 squamous cell carcinomas analyzed, relapse-free rates at 24 months were 55% in tumors with c-myc overexpression and 100% in case of tumors with no c-myc overexpression, respectively. The results suggest the possibility that activation of the c-myc oncogene is involved in tumor progression.
UR - http://www.scopus.com/inward/record.url?scp=0026705039&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026705039&partnerID=8YFLogxK
U2 - 10.1016/0090-8258(92)90220-D
DO - 10.1016/0090-8258(92)90220-D
M3 - Article
C2 - 1326470
AN - SCOPUS:0026705039
SN - 0090-8258
VL - 46
SP - 298
EP - 303
JO - Gynecologic Oncology
JF - Gynecologic Oncology
IS - 3
ER -